Sexual and reproductive health and HIV services: Integrating HIV/AIDS and cervical cancer prevention and control

International Journal of Gynecology and Obstetrics

Volumn 121, Issue SUPPL1, 2013, Pages

  Belhadj, Hedia ^a   Rasanathan, Jennifer J K ^b   Denny, Lynette ^c   Broutet, Nathalie ^d  

^a UNAIDS   (Switzerland)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Cervical cancer; HIV; HPV; Immune deficiency; Integration; Primary prevention; Screening; Secondary prevention; Sexual and reproductive health

Indexed keywords

WART VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; HEALTH SERVICE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTEGRATIVE MEDICINE; MIXED INFECTION; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; RISK FACTOR; SEXUAL HEALTH; TREATMENT RESPONSE; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS;

EID: 84875938490     PISSN: 00207292     EISSN: 18793479     Source Type: Journal    
DOI: 10.1016/j.ijgo.2013.02.002     Document Type: Article

References (62)

1. UNAIDS website Estimated HIV prevalence Available at: http://www.unaids.org/en/dataanalysis/datatools/aidsinfo/ [Accessed December 12, 2012]
2. UNAIDS Chronic care of HIV and noncommunicable diseases: How to leverage the HIV experience 2011 UNAIDS Geneva [Available at: http://www.unaids.org/en/ media/unaids/contentassets/documents/unaidspublication/2011/20110526-JC2145- Chronic-care-of-HIV.pdf ]
3. N.S. Levitt, K. Steyn, J. Dave, and D. Bradshaw Chronic noncommunicable diseases and HIV-AIDS on a collision course: relevance for health care delivery, particularly in low-resource settings - insights from South Africa Am J Clin Nutr 94 6 2011 1690S 1696S
4. R. Beaglehole, J. Epping-Jordan, V. Patel, M. Chopra, S. Ebrahim, and M. Kidd Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care Lancet 372 9642 2008 940 949
5. G.M. Clifford, S. Gallus, R. Herrero, N. Muñoz, P.J. Snijders, and S. Vaccarella Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis Lancet 366 9490 2005 991 998
6. E.F. Dunne, E.R. Unger, M. Sternberg, G. McQuillan, D.C. Swan, and S.S. Patel Prevalence of HPV infection among females in the United States JAMA 297 8 2007 813 819
7. P. Stamataki, A. Papazafiropoulou, I. Elefsiniotis, M. Giannakopoulou, H. Brokalaki, and E. Apostolopoulou Prevalence of HPV infection among Greek women attending a gynecological outpatient clinic BMC Infect Dis 10 2010 27
8. P. Dursun, S.S. Senger, H. Arslan, E. Kuşçu, and A. Ayhan Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient clinic BMC Infect Dis 9 2009 191
9. N. Muñoz, X. Castellsagúe, M. Berrington de González, and L. Gissmann HPV in the etiology of human cancer Vaccine 24S3 2006 S3/1-S3/10
10. M. Schiffman, P.E. Castle, J. Jeronimo, A.C. Rodriguez, and S. Wacholder Human papillomavirus and cervical cancer Lancet 370 9590 2007 890 907
11. Alliance for Cervical Cancer Prevention Planning and implementing cervical cancer prevention and control programs: a manual for managers 2004 ACPP Seattle [Available at: http://whqlibdoc.who.int/paho/2004/a92126.pdf ]
12. M. Frisch, R.J. Biggar, and J.J. Goedert Human papillomavirus-associated cancers in patients with human immunodeficiency virusi and acquired immunodeficiency syndrome J Natl Cancer Inst 92 18 2000 1500 1510
13. A.K. Chaturvedi, E.A. Engels, R.M. Pfeiffer, B.Y. Hernandez, W. Xiao, and E. Kim Human papillomavirus and rising oropharyngeal cancer incidence in the United States J Clin Oncol 29 32 2011 4294 4301
14. L. Marklund, and L. Hammarstedt Impact of HPV in oropharyngeal cancer J Oncol 2011 2011 509036
15. P. Farmer, J. Frenk, F.M. Knaul, L.N. Shulman, G. Alleyne, and L. Armstrong Expansion of cancer care and control in countries of low and middle income: a call to action Lancet 376 9747 2010 1186 1193
16. A.C. de Andrade, P.M. Luz, L. Velasque, V.G. Veloso, R.I. Moreira, and F. Russomano Factors associated with colposcopy-histopathology confirmed cervical intraepithelial neoplasia among HIV-infected women from Rio de Janeiro, Brazil PLoS One 6 3 2011 e18297
17. C. Ng'andwe, J.J. Lowe, P.J. Richards, L. Hause, C. Wood, and P. Angeletti The distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa BMC Infect Dis 7 2007 77
18. M.D. Guimaraes, B. Grinsztejn, V.H. Melo, G.M. Rocha, L.N. Campos, and J.H. Pilotto Anal HPV prevalence and associated factors among HIV-seropositive men under antiretroviral treatment in Brazil J Acquir Immune Defic Syndr 57 Suppl. 3 2011 S217 S224
19. B. Auvert, D. Marais, P. Lissouba, K. Zarca, G. Ramjee, and A.L. Williamson High-risk human papillomavirus is associated with HIV acquisition among South African female sex workers Infect Dis Obstet Gynecol 2011 2011 692012
20. P.B. Namujju, T. Waterboer, C. Banura, R. Muwonge, E.K. Mbidde, and R. Byaruhanga Risk of seropositivity to multiple oncogenic human papillomavirus types among human immunodeficiency virus-positive and -negative Ugandan women J Gen Virol 92 Pt 12 2011 2776 2783
21. H. De Vuyst, G. Ndirangu, M. Moodley, V. Tenet, B. Estambale, and C.J. Meijer Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa Int J Cancer 131 4 2012 949 955
22. L. Denny, R. Boa, A.L. Williamson, B. Allan, D. Hardie, and R. Stan Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women Obstet Gynecol 111 6 2008 1380 1387
23. D.C. Beachler, K.M. Weber, J.B. Margolick, H.D. Strickler, R.D. Cranston, and R.D. Burk Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults Cancer Epidemiol Biomarkers Prev 21 1 2012 122 133
24. Z.M. Chirenje, S. Rusakaniko, V. Akino, M. Munjoma, and M. Mlingo Effect of HIV disease in treatment outcome of cervical squamous intraepithelial lesions among Zimbabwean women J Low Genit Tract Dis 7 1 2003 16 21
25. M.I. Lima, A. Tafuri, A.C. Araújo, Lima L. de Miranda, and V.H. Melo Cervical intraepithelial neoplasia recurrence after conization in HIV-positive and HIV-negative women Int J Gynecol Obstet 104 2 2009 100 104
26. T. Omar, S. Schwartz, C. Hanrahan, T. Modisenyane, N. Tshabangu, and J.E. Golub Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort AIDS 25 1 2011 87 94
27. C.L. Curry, Y.H. Sage, O. Vragovic, and E.A. Stier Minimally abnormal Pap testing and cervical histology in HIV-infected women J Womens Health (Larchmt) 21 1 2012 87 91
28. A.K. Chaturvedi, M.M. Madeleine, R.J. Biggar, and E.A. Engels Risk of human papillomavirus-associated cancers among persons with AIDS J Natl Cancer Inst 101 16 2009 1120 1130
29. S.G. Parisi, M. Cruciani, R. Scaggiante, C. Boldrin, S. Andreis, and F.D. Dal Bello Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men BMC Infect Dis 11 2011 150
30. K. Anastos, D.R. Hoover, R.D. Burk, A. Cajigas, Q. Shi, and D.K. Singh Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women PLoS One 5 10 2010 e13525
31. J. Palefsky Biology of HPV in HIV infection Adv Dent Res 19 1 2006 99 105
32. D.H. Adler The impact of HAART on HPV-related cervical disease Curr HIV Res 8 7 2010 493 497
33. A.N. Burchell, F. Coutlée, P.P. Tellier, J. Hanley, and E.L. Franco Genital transmission of human papillomavirus in recently formed heterosexual couples J Infect Dis 204 11 2011 1723 1729
34. T.D. Mastro, G.A. Satten, T. Nopkesorn, S. Sangkharomya, and I.M. Longini Probability of female-to-male transmission of HIV-1 in Thailand Lancet 343 8891 1994 204 207
35. World Health Organization Comprehensive cervical cancer control: a guide to essential practice 2006 WHO Geneva [Available at: http://whqlibdoc.who.int/ publications/2006/9241547006-eng.pdf ]
36. B. Auvert, D. Taljaard, E. Lagarde, J. Sobngwi-Tambekou, R. Sitta, and A. Puren Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial PLoS Med 2 11 2005 e298
37. R.C. Bailey, S. Moses, C.B. Parker, K. Agot, I. Maclean, and J.N. Krieger Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial Lancet 369 9562 2007 643 656
38. R.H. Gray, G. Kigozi, D. Serwadda, F. Makumbi, S. Watya, and F. Nalugoda Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial Lancet 369 9562 2007 657 666
39. N. Larke, S.L. Thomas, Silva I. Dos Santos, and H.A. Weiss Male circumcision and human papillomavirus infection in men: a systematic review and meta-analysis J Infect Dis 204 9 2011 1375 1390
40. B.J. Morris, R.H. Gray, X. Castellsague, F.X. Bosch, D.T. Halperin, and J.H. Waskett The strong protective effect of circumcision against cancer of the penis Adv Urol 2011 2011 812368
41. M.J. Wawer, A.A. Tobian, G. Kigozi, X. Kong, P.E. Gravitt, and D. Serwadda Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda Lancet 377 9761 2011 209 218
42. A.A. Tobian, X. Kong, M.J. Wawer, G. Kigozi, P.E. Gravitt, and D. Serwadda Circumcision of HIV-infected men and transmission of human papillomavirus to female partners: analyses of data from a randomized trial in Rakai, Uganda Lancet Infect Dis 11 8 2011 604 612
43. M. Schiffman, and S. Wacholder Success of HPV vaccination is now a matter of coverage Lancet Oncol 13 1 2012 10 12
44. A.R. Giuliano, M.F. van der Loeff, and A.G. Nyitray Circumcised HIV-infected men and HPV transmission Lancet Infect Dis 11 8 2011 581 582
45. ClinicalTrials.gov Available at: http://clinicaltrials.gov/ct2/results? term=HPV+Vaccine+and+HIV&pg=2
46. J. Kahn, J. Xu, B. Kapogiannis, B. Rudy, N. Liu, and R. Gonin Immunogenicity of the HPV-6, -11, -16, -18 vaccine in HIV-positive young women XIX International AIDS Conference, July 22-27, 2012, Washington, DC Abstract WEAB0203 2012
47. J.E. Graham, and A. Mishra Global challenges of implementing human papillomavirus vaccines Int J Equity Health 10 1 2011 27
48. T.G. Harris, R.D. Burk, J.M. Palefsky, L.S. Massad, J.Y. Bang, and K. Anastos Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results JAMA 293 12 2005 1471 1476
49. P. Bonanni, M. Levi, N.B. Latham, A. Bechini, E. Tiscione, and P. Lai An overview on the implementation of HPV vaccination in Europe Hum Vaccin 7 Suppl. 128-35 2011
50. M.H. Chung, K.P. McKenzie, B.A. Richardson, G.C. John-Stewart, R.W. Coombs, and H. De Vuyst Cervical HIV-1 RNA shedding after cryotherapy among HIV-positive women with cervical intraepithelial neoplasia stage 2 or 3 AIDS 25 15 2011 1915 1919
51. Y. Adam, C.J. van Gelderen, G. de Bruyn, J.A. McIntyre, D.A. Turton, and N.A. Martinson Predictors of persistent cytologic abnormalities after treatment of cervical intraepithelial neoplasia in Soweto, South Africa: a cohort study in a HIV high prevalence population BMC Cancer 8 2008 211
52. V.D. Tsu, and C.E. Levin Making the case for cervical cancer prevention: what about equity? Reprod Health Matters 16 32 2008 104 112
53. CanTreat International Scaling up cancer diagnosis and treatment in developing countries: what can we learn from the HIV/AIDS epidemic? Ann Oncol 21 4 2010 680 682
54. F.M. Knaul, and P. Farmer Overview F.M. Knaul, J. Frenk, L. Shulman, For the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries Closing the Cancer Divide: A Blueprint to Expand Access in Low and Middle Income Countries 2011 Harvard Global Equity Initiative Boston, MA
55. World Health Organization, and UNAIDS Guidance on provider-initiated HIV testing and counselling in health facilities 2007 WHO Geneva Available at: http://whqlibdoc.who.int/publications/2007/9789241595568-eng.pdf
56. M. Arbyn, M. Kyrgiou, C. Simoens, A.O. Raifu, G. Koliopoulos, and P. Martin-Hirsch Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis BMJ 337 2008 a1284
57. E. Chellini, G. Gorini, G. Carreras, L. Giordano, E. Anghinoni, and A. Iossa The Pap smear screening as an occasion for smoking cessation and physical activity counselling: baseline characteristics of women involved in the SPRINT randomized controlled trial BMC Public Health 11 2011 906
58. R. Atun, and J. Bataringaya Building a durable response to HIV/AIDS: implications for health systems J Acquir Immune Defic Syndr 57 Suppl. 2 2011 S91 S95
59. UNAIDS UNAIDS position statement - leveraging the AIDS response to strengthen health systems Available at: http://www.unaids.org/en/media/unaids/ contentassets/documents/document/2011/07/20110721-JC2195-HSS-Statement-en.pdf
60. R. Das, K. Biswas, P. Panda, M.E. Khan, and R. Homan Strengthening Financial Sustainability through Integration of Voluntary Counseling and Testing Services with Other Reproductive Health Services Available at: http://www.popcouncil.org/pdfs/frontiers/FR-FinalReports/India-CINI.pdf January 2007
61. W. Liambila, I. Askew, R. Ayisi, M. Gathitu, J. Mwangi, and R. Homan Feasibility, Acceptability, Effect and Cost of Integrating Counseling and Testing for HIV within Family Planning Services in Kenya FRONTIERS Final Report 2008 The Population Council Washington DC
62. S. Sweeney, C.D. Obure, C.B. Maier, R. Greener, K. Dehne, and A. Vassall Costs and efficiency of integrating HIV/AIDS services with other health services: a systematic review of evidence and experience Sex Transm Infect 88 2 2012 85 99